Time from acceptance to publication*:
Impact Factor:
Citescore rank:
2023 total content views:
2023 total Altmetric mentions:

Aims and scope

BMJ Open Ophthalmology is the online-only, open access companion to British Journal of Ophthalmology. The journal publishes high quality, peer-reviewed articles on basic, translational and clinical science, covering all aspects of ophthalmology and vision science. BMJ Open Ophthalmology aims to:
  • Publish a broad range of articles of particular clinical, scientific, educational or surgical value on a rapid publication schedule
  • Facilitate a close interaction between basic, translational and clinical sciences through publication and fostering interdisciplinary research
  • Provide an interactive digital platform that is freely available, unrestricted and immediately accessible
  • Provoke scientific debate and clinical commentary in which the readership, authors and public can engage and contribute through social media and multimedia


BMJ Open Ophthalmology is owned by BMJ.

Editorial board

Led by Editor-in-Chief Prof Stephen Kaye; more information about the wider BMJ Open Ophthalmology editorial team can be found on the Editorial Board page.

Journal information

Publication Model
Open access
Continuous online publication
Launch date
Digital Archives
Indexed by
Web of Science Core Collection: Emerging Sources Citation Index; Scopus; MEDLINE; PubMed Central; DOAJ; Google Scholar
Peer review model
Single anonymised; the names of reviewers are hidden from the author
Online ISSN

Journal Statistics 2023

Acceptance rate: 30%
Speed Time to first decision without review: 2 days (median) Time to first decision with review: 43 days (median) Time from acceptance to publication: 18 days (median)
Impact Impact Factor category: Ophthalmology Impact factor (JCR): 2.4 5 year Impact Factor: 2.8 Journal Citation Indicator (JCI): 0.91 Eigenfactor Score: 0.00198 Citescore: 3.5 Citescore rank: 43/130 SciMago Journal Rank: 0.913
Reach 2023 total content views: 180,829 2023 total Altmetric mentions: 245
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Related publications

British Journal of Ophthalmology is an international peer-reviewed journal for ophthalmologists and visual science specialists. British Journal of Ophthalmology publishes clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. It also provides major reviews and also publishes manuscripts covering regional issues in a global context.


BMJ Open Ophthalmology is affiliated with the European Eye Bank Association (EEBA), a technical-scientific association comprising individual and institutional members from 27 countries. Founded with the simple objective of sharing information regarding eye-banking, the Association is today the leading pan-national association in Europe dedicated to the advancement of eye-banking and an authoritative reference point for eye banks wishing to work according to quality standards.
Women in Vision UK logo
BMJ Open Ophthalmology is affiliated with Women in Vision UK. WVUK supports and promotes women in all areas of ophthalmology, and vision sciences. The network fosters new collaborations, establishes mentoring connections, and raises the profile of women working in vision across the UK.
COPE logo
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Equator logo
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.